🩺 Record Detail
Patient Info
Name: Unknown
Age: Unknown
Date: 2026-09-04 19:45:35
Transcript
Doctor: History is previous splenomegaly and polycystic kidneys noted in February needs a three-month repeat, not done. Also AAA question mark comparison February 27th, 2026. Findings. Splenomegaly reidentified measures 17 centimeters mid-clavicular line, slightly increased from 16 centimeters. Previously there was a stellate macrolobulated hypodense lesion within the ventral pole of the spleen. Measures 32 by 27 millimeters, not significantly changed from 29 by 27 millimeters. Aorta normal caliber, no bowel obstruction. Appendix is visualized then as unremarkable. No free fluid or free air. Spleen liver measures 19 centimeters consistent with mild hepatomegaly. There is diffuse hypodensity to the hepatic parenchyma suggestive of steatosis. Reidentified numerous bilateral renal cysts. Size and distribution of the cysts largely similar to prior. Some have slightly increased in size, for example right upper pole measuring 38 millimeters, previously 30 millimeters. Left upper pole measuring 6 centimeters, not significantly changed. Background, renal parenchyma is unremarkable with preserved corticomedullary differentiation. No hydronephrosis. Unchanged mid mesenteric calcifications. Impression. Number one, slight progression in splenomegaly with splenic lesion, not significantly changed. The lesion could represent a hemangioma or hematoma. It does not appear consistent with a simple cyst. It could be further characterized with ultrasound as a complementary modality and triphysic MRI where non-diagnostic. Number two, autosomal dominant polycystic kidney disease similar to prior. Number three, unchanged hepatomegaly. Number four, no abdominal aortic aneurysm. Number five, no acute intra-abdominal abnormalities. Number six, incidental findings as described above. Please add a template to the finding section of this report. Include relevant hepatobiliary findings under the hepatobiliary template. Also include gastrointestinal and genital urinary as primary categories and organize the data accordingly.
Clinical Notes
SOAP Clinical Note
Subjective
The patient has a history of splenomegaly and polycystic kidneys noted in February. A three-month follow-up was recommended but not completed. The patient is being evaluated for abdominal aortic aneurysm (AAA) with a comparison to findings from February 27th, 2026.
Objective
- Splenomegaly reidentified, measuring 17 cm at the mid-clavicular line, slightly increased from 16 cm.
- A stellate macrolobulated hypodense lesion within the ventral pole of the spleen measures 32 by 27 mm, not significantly changed from 29 by 27 mm.
- Aorta is of normal caliber.
- No bowel obstruction; appendix is unremarkable.
- No free fluid or free air present.
- Liver measures 19 cm, consistent with mild hepatomegaly.
- Diffuse hypodensity in hepatic parenchyma suggestive of steatosis.
- Numerous bilateral renal cysts reidentified; size and distribution largely similar to prior, with some increase in size (e.g., right upper pole 38 mm, previously 30 mm; left upper pole 6 cm, unchanged).
- Background renal parenchyma is unremarkable with preserved corticomedullary differentiation.
- No hydronephrosis.
- Unchanged mid mesenteric calcifications.
Assessment
- Slight progression in splenomegaly with a splenic lesion, not significantly changed. The lesion could represent a hemangioma or hematoma, and further characterization with ultrasound or triphasic MRI is suggested if non-diagnostic.
- Autosomal dominant polycystic kidney disease, similar to prior findings.
- Unchanged mild hepatomegaly.
- No abdominal aortic aneurysm.
- No acute intra-abdominal abnormalities.
- Incidental findings as described.
Plan
- Follow-up imaging with ultrasound and potentially triphasic MRI for further characterization of the splenic lesion.
- Continue monitoring of polycystic kidney disease and hepatomegaly.
- No immediate intervention required for abdominal aortic aneurysm as it is not present.
- Reassess in three months or as clinically indicated based on progression of findings.